Pay in 4 interest-free payments of $6.80 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Key details Compounded GLP-1s Semaglutide injections Semaglutide microdose Semaglutide oral tablets Semaglutide oral drops Tirzepatide injections Tirzepatide oral tablets Tirzepatide oral drops Tirzepatide microdose Branded GLP-1s Ozempic Mounjaro Rybelsus Trulicity Wegovy Zepbound Saxenda/Victoza Mochi Health does not offer compounded tirzepatide in oral tablet, oral drop, or microdose formats
What are Ozempic, Wegovy, Mounjaro and Zepbound approved to treat
retail pharmacies and telehealth providers is expected soon
Semaglutide is a great option for those who wish to lose weight, improve their appearance, and change their overall health
It also derives from Eli Lillys SURMOUNT-4 clinical trial results which showed 20% average weight loss over 36 weeks among people utilized a maximum tolerated dose of 10 mg or 15 mg of tirzepatide once-weekly
Discovery of the once-weekly GLP-1 analogue semaglutide
